Is Bluejay Diagnostics, Inc. (BJDX) a Buy, Sell, or Hold?
NASDAQ : BJDX
Bluejay Diagnostics, Inc.
$1.45 USD
$0.15 (11.54%)
- Volume
- 1.44M
- Average Volume
- 4.01M
- Market Capitalization
- $657.63K
- P/E Ratio
- -0.09
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $16.68
- Year Low
- $1.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.81
Company Overview
NASDAQ
Indranil Dey
Medical - Devices
Healthcare
BJDX
6
US
USD
Liquidity Metrics
0.02
2.81
2.81
2.61
0.00
Sales & Valuation
-$
0.00
0.16
-0.10
-14.81
Profitability
-$15.25
-$6.85M
0.00%
0.00%
-144.27%
-123.30%
P/E Metrics
-0.09
0.00
0.00
Analyst Price Target & Rating
3/5
1 Analysts
%
Poll Results
About Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Stock
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Further ... more, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
2026-06-05 20:13:00
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants
What's Going On With Bluejay Diagnostics Shares On Wednesday?
2026-06-03 11:48:19
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares are trading lower on Wednesday. On Tuesday, the company disclosed a private placement that aims to raise up to $23.6 million.
2026-06-02 12:19:00
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
2026-06-02 06:30:00
ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”) (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing for critical care, today announced a strategic partnership with Argonaut Manufacturing Services (“Argonaut”) to support the advancement of Bluejay's Symphony™ platform.
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
2026-05-07 16:01:00
ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today provided a corporate update highlighting progress achieved during the first quarter of 2026 and recent operational developments related to its Symphony™ near-patient diagnostic platform.
Critical Contrast: Bluejay Diagnostics (NASDAQ:BJDX) & STERIS (NYSE:STE)
2026-04-27 02:22:53
Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) and STERIS (NYSE: STE - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Analyst Ratings This is a breakdown of recent ratings
Frequently Asked Questions
-
What is the current Bluejay Diagnostics, Inc. (BJDX) stock price?
-
Bluejay Diagnostics, Inc.(NASDAQ:BJDX) stock price is $1.45 in the last trading session. During the trading session, BJDX stock reached the peak price of $16.68 while $1.03 was the lowest point it dropped to. The percentage change in BJDX stock occurred in the recent session was 11.54% while the dollar amount for the price change in BJDX stock was $0.15.
-
BJDX's industry and sector of operation?
-
The NASDAQ listed BJDX is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of BJDX?
-
Kevin Vance | Chief Commercial Officer
Mark W. Feinberg | Chief Medical Advisor
Indranil Dey | Principal Financial, Accounting & Executive Officer, President, Chief Executive Officer and Director
|
| -
How many employees does BJDX have?
-
Number of BJDX employees currently stands at 6. BJDX operates from 360 Massachusetts Avenue, Acton, MA 01720, US.
-
Link for BJDX official website?
-
Official Website of BJDX is: https://bluejaydx.com
-
How do I contact BJDX?
-
BJDX could be contacted at phone #844 327 7078 and can also be accessed through its website. BJDX operates from 360 Massachusetts Avenue, Acton, MA 01720, US.
-
How many shares of BJDX are traded daily?
-
The average number of BJDX shares traded daily for last 3 months was 4.01M.
-
What is the market cap of BJDX currently?
-
The market value of BJDX currently stands at $657.63K with its latest stock price at $1.45